Conclusions: These findings suggest that IL-1β, IL-6, and RIPK3 may contribute to the pathogenesis of SJS/TEN and highlight their potential as targets for therapeutic intervention. The gene discussed is IL6; the disease is Schwartz-Jampel syndrome.